Careers

    Genexine to focus on global drug development and commercializationNear term milestones should drive shareholder valueRenewed effort to expand pipeline with an emphasis on novel, differentiated productsSEOUL, South Korea-...

    Excellent safety continues to be observed in ongoing Phase 2a dose optimization study (OVX836-003)Phase 2a dose optimization study extended to elderly population cohort (OVX836-003)Additional Phase 2a trial combining OVX...

    NEWS RELEASE - REGULATED INFORMATION25 May 2022, 4:00 p.m.EDT / 22:00 CETMDxHealth Announces Resultsof its Annual and Extraordinary General Shareholders’ Meetings and Resignation of DirectorIRVINE, CA, and HERSTAL, BELG...

    Kasper Roet, Ph.D., founder and CEO, discusses new insights into human genetics and stem cell technology to provide genetically validated targets for sporadic ALS patient populations Angela Genge, M.D., chief medical off...

    For months, Russian artillery has bombarded Ukraine as it continues its invasion, causing untold death and destruction to the lives of the people in that country. The invasion also disrupted a thriving chemical productio...

    NEWTOWN, Pa., May 24, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that, effective May 2...

    ALLEN, Texas, May 24, 2022 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced that its Board of Directors declared a quarterly dividend of $1.95 per share on its outstanding shares of Common Stock. Thi...

    May 25, 2022 12:00 UTCWith fundamental advancements made by the founding team, Terremoto’s lysine-based covalency platform holds the potential to expand the covalent drug alphabet and create both best-in-class and first...

    GAINESVILLE, Fla.--(BUSINESS WIRE)-- Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced successful first surgeries using the Equino...

    Vancouver, British Columbia--(Newsfile Corp. - May 24, 2022) - Nirvana Life Sciences Inc. (CSE: NIRV) (Nirvana or the "Company"), a western Canadian based life sciences company aimed at developing non-addictive chronic p...

    For the third straight year, Lumenis wins award recognizing outstanding medical companies and technologiesYOKNE’AM ILLIT, Israel--(BUSINESS WIRE)-- Lumenis Be., a leading energy-based medical device company for aestheti...

    Deliveries to start immediately aiming to ensure a rapid response to the current monkeypox outbreakCompany upgrades its financial guidance for 2022COPENHAGEN, Denmark, May 25, 2022 – Bavarian Nordic A/S (OMX: BAVA) anno...

    System creates 3D models of the heart with unprecedented anatomical details, allowing physicians to better plan and personalize therapeutic interventionsCAMBRIDGE, Mass. and BORDEAUX, France, May 24, 2022 /PRNewswire/ --...

    Toronto, Ontario--(Newsfile Corp. - May 24, 2022) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a biotechnology company, researching, developing, and commercializing therapeutics ...

    Kaiser Permanente study suggests that for patients with severe asymptomatic carotid stenosis who do not have surgery medical management alone may reduce stroke riskOAKLAND, Calif. , May 24, 2022 /PRNewswire/ -- The risk ...

    Courtesy of Sanchit Khanna/Hindustan Times via Getty ImagesThe U.S.Food and Drug Administrationlifted a second clinical holdonOcugen’s clinical studies of Covaxin, a vaccine for COVID-19.The company was in the midst of ...

    CAMBRIDGE, Mass., May 25, 2022 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq: EVLO), a clinical stage biotechnology company developing a new modality of orally delivered medicines, today announced that it has enter...

    DALLAS, May 25, 2022 /PRNewswire/ -- Nanoscope Therapeutics, Inc., a clinical-stage biotechnology company developing gene therapies to treat retinal degenerative diseases, today announced that Naveed Shams MD, PhD, and T...

    SEOUL, South Korea--(BUSINESS WIRE)-- Genexine (KOSDAQ: 095700), a publicly traded, clinical stage biopharmaceutical company committed to the discovery and development of novel biologics for the treatment of unmet medica...

    Saint Herblain(France), May 25, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the successful completion of the lot-to-lot Phase 3 trial of its single-shot chikunguny...